Theravance Biopharma (TBPH)
(Delayed Data from NSDQ)
$8.74 USD
-0.11 (-1.24%)
Updated May 20, 2022 04:00 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Brokerage Recommendations
Current ABR | 3.08 |
ABR (Last week) | 3.08 |
# of Recs in ABR | 4 |
Average Target Price | $12.00 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 147 of 252 |
Current Quarter EPS Est: | 0.08 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 1 | 1 | 1 |
Hold | 1 | 1 | 2 | 2 | 2 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 3.08 | 3.08 | 2.88 | 2.88 | 2.88 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.